Pfizer and BioNTech have struck a deal for South Africa’s Biovac Institute to help manufacture around 100 million doses a year of their Covid-19 vaccine for the African Union.
Get the best South African technology news and analysis delivered to your e-mail inbox every morning.
Pfizer and BioNTech have struck a deal for South Africa’s Biovac Institute to help manufacture around 100 million doses a year of their Covid-19 vaccine for the African Union.
TechCentral uses cookies to enhance its offerings. Consenting to these technologies allows us to serve you better. Not consenting or withdrawing consent may adversely affect certain features and functions of the website.
